These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23915136)

  • 41. Thyroid hormone regulation of mRNAs encoding thyrotropin beta-subunit, glycoprotein alpha-subunit, and thyroid hormone receptors alpha and beta in brain, pituitary gland, liver, and gonads of an adult teleost, Pimephales promelas.
    Lema SC; Dickey JT; Schultz IR; Swanson P
    J Endocrinol; 2009 Jul; 202(1):43-54. PubMed ID: 19380459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thyroid Hormone Signaling and the Liver.
    Ritter MJ; Amano I; Hollenberg AN
    Hepatology; 2020 Aug; 72(2):742-752. PubMed ID: 32343421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease.
    Smith AG; Muscat GE
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2047-63. PubMed ID: 15922648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thyroid hormone signaling and homeostasis during aging.
    Bowers J; Terrien J; Clerget-Froidevaux MS; Gothié JD; Rozing MP; Westendorp RG; van Heemst D; Demeneix BA
    Endocr Rev; 2013 Aug; 34(4):556-89. PubMed ID: 23696256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic Messengers: Thyroid Hormones.
    Sinha RA; Yen PM
    Nat Metab; 2024 Apr; 6(4):639-650. PubMed ID: 38671149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of thyroid hormone analogs on lipid metabolism and thermogenesis.
    Ribeiro MO
    Thyroid; 2008 Feb; 18(2):197-203. PubMed ID: 18279020
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A mouse model of resistance to thyroid hormone produced by somatic gene transfer of a mutant thyroid hormone receptor.
    Hayashi Y; Mangoura D; Refetoff S
    Mol Endocrinol; 1996 Jan; 10(1):100-6. PubMed ID: 8838149
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cholesterol-lowering therapy for the treatment of nonalcoholic fatty liver disease: an update.
    Musso G; Cassader M; Gambino R
    Curr Opin Lipidol; 2011 Dec; 22(6):489-96. PubMed ID: 21986643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T3/TRs axis in hepatocellular carcinoma: new concepts for an old pair.
    Perra A; Plateroti M; Columbano A
    Endocr Relat Cancer; 2016 Aug; 23(8):R353-69. PubMed ID: 27353037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemia.
    Shiohara H; Nakamura T; Kikuchi N; Ozawa T; Nagano R; Matsuzawa A; Ohnota H; Miyamoto T; Ichikawa K; Hashizume K
    Bioorg Med Chem; 2012 Jun; 20(11):3622-34. PubMed ID: 22542282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isoform-dependent actions of thyroid hormone nuclear receptors: lessons from knockin mutant mice.
    Cheng SY
    Steroids; 2005; 70(5-7):450-4. PubMed ID: 15862829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thyroid receptor subtypes: structure and function in fish.
    Nelson ER; Habibi HR
    Gen Comp Endocrinol; 2009 Mar; 161(1):90-6. PubMed ID: 18840444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thyroid hormone receptor β mediates thyroid hormone effects on bone remodeling and bone mass.
    Monfoulet LE; Rabier B; Dacquin R; Anginot A; Photsavang J; Jurdic P; Vico L; Malaval L; Chassande O
    J Bone Miner Res; 2011 Sep; 26(9):2036-44. PubMed ID: 21594896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Thyroid hormones and lipid metabolism].
    Sasaki S; Kawai K; Honjo Y; Nakamura H
    Nihon Rinsho; 2006 Dec; 64(12):2323-9. PubMed ID: 17154100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential therapeutic applications of thyroid hormone analogs.
    Brenta G; Danzi S; Klein I
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):632-40. PubMed ID: 17710084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone.
    Takeda T; Suzuki S; Liu RT; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2033-40. PubMed ID: 7608251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective thyroid hormone receptor modulators.
    Raparti G; Jain S; Ramteke K; Murthy M; Ghanghas R; Ramanand S; Ramanand J
    Indian J Endocrinol Metab; 2013 Mar; 17(2):211-8. PubMed ID: 23776891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-alcoholic fatty liver disease and the statins treatment.
    Dima A; Marinescu AG; Dima AC
    Rom J Intern Med; 2012; 50(1):19-25. PubMed ID: 22788090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and biological activity of novel thyroid hormone analogues: 5'-aryl substituted GC-1 derivatives.
    Chiellini G; Nguyen NH; Apriletti JW; Baxter JD; Scanlan TS
    Bioorg Med Chem; 2002 Feb; 10(2):333-46. PubMed ID: 11741782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.